[go: up one dir, main page]

PH31668A - 14alpha, 17alpha -Ethano -16alpha -hydroxy-extratrienes. - Google Patents

14alpha, 17alpha -Ethano -16alpha -hydroxy-extratrienes.

Info

Publication number
PH31668A
PH31668A PH1640A PH1640A PH31668A PH 31668 A PH31668 A PH 31668A PH 1640 A PH1640 A PH 1640A PH 1640 A PH1640 A PH 1640A PH 31668 A PH31668 A PH 31668A
Authority
PH
Philippines
Prior art keywords
14alpha
17alpha
16alpha
ethano
oestratriene
Prior art date
Application number
PH1640A
Other languages
English (en)
Inventor
Kirsch Gerald
Neef Gunther
Laurent Henry
Wiechert Rudolf
Esperling Peter
Elge Walter
James R Bull
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3939893A external-priority patent/DE3939893A1/de
Priority claimed from DE3939894A external-priority patent/DE3939894A1/de
Priority claimed from DE4033871A external-priority patent/DE4033871A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of PH31668A publication Critical patent/PH31668A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Fats And Perfumes (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH1640A 1989-11-29 1990-11-28 14alpha, 17alpha -Ethano -16alpha -hydroxy-extratrienes. PH31668A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3939893A DE3939893A1 (de) 1989-11-29 1989-11-29 14(alpha),17(alpha)-etha(e)no-16ss-hydroxy-estratriene
DE3939894A DE3939894A1 (de) 1989-11-29 1989-11-29 14(alpha),17(alpha)-ethano-16(alpha)-hydroxy-estratriene
DE4033871A DE4033871A1 (de) 1990-10-22 1990-10-22 Verfahren zur herstellung von 14(alpha), 17(alpha)-etheno- und ethano-estriolen

Publications (1)

Publication Number Publication Date
PH31668A true PH31668A (en) 1999-01-18

Family

ID=27200525

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1640A PH31668A (en) 1989-11-29 1990-11-28 14alpha, 17alpha -Ethano -16alpha -hydroxy-extratrienes.

Country Status (21)

Country Link
US (1) US5529993A (fr)
EP (1) EP0430386B1 (fr)
JP (1) JP2996723B2 (fr)
KR (1) KR100203003B1 (fr)
CN (2) CN1057769C (fr)
AT (1) ATE122053T1 (fr)
AU (1) AU649239B2 (fr)
CA (1) CA2069880A1 (fr)
CZ (1) CZ286259B6 (fr)
DE (1) DE59009011D1 (fr)
DK (1) DK0430386T3 (fr)
ES (1) ES2074531T3 (fr)
FI (1) FI102902B (fr)
HU (1) HU220217B (fr)
IE (1) IE67321B1 (fr)
IL (1) IL96501A (fr)
NO (1) NO301232B1 (fr)
PH (1) PH31668A (fr)
PT (1) PT96035B (fr)
RU (1) RU2087479C1 (fr)
WO (1) WO1991008219A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132182A1 (de) * 1991-09-24 1993-03-25 Schering Ag 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
DE4222316A1 (de) * 1992-07-03 1994-01-05 Schering Ag Verfahren zur Herstellung von Etheno- und Ethano-16â,17µ-Steroiddiolen und deren Derivaten
DE4429398C2 (de) * 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
CN113999276B (zh) * 2020-07-28 2023-08-15 威智医药股份有限公司 一种去乙酰毛花苷中间体的提纯方法以及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE808679C (de) * 1948-10-19 1951-07-19 Hansen Neuerburg & Co Mit Leitflaechen versehene Propelleranordnung fuer Schiffe
DE3628189A1 (de) * 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE3808679A1 (de) * 1988-03-11 1989-09-21 Schering Ag Verfahren zur herstellung von 14,17(alpha)-etheno-1,3,5(10)-estratrienen

Also Published As

Publication number Publication date
NO921910D0 (no) 1992-05-14
HU220217B (hu) 2001-11-28
ATE122053T1 (de) 1995-05-15
FI102902B1 (fi) 1999-03-15
IE67321B1 (en) 1996-03-20
CA2069880A1 (fr) 1991-05-30
CN1117050A (zh) 1996-02-21
PT96035A (pt) 1991-09-13
CZ286259B6 (cs) 2000-02-16
CZ594390A3 (cs) 1999-11-17
CN1057769C (zh) 2000-10-25
EP0430386B1 (fr) 1995-05-03
CN1031061C (zh) 1996-02-21
FI920843A0 (fi) 1992-02-26
KR100203003B1 (ko) 1999-06-15
US5529993A (en) 1996-06-25
RU2087479C1 (ru) 1997-08-20
IE904316A1 (en) 1991-06-05
ES2074531T3 (es) 1995-09-16
AU649239B2 (en) 1994-05-19
NO921910L (no) 1992-05-14
DE59009011D1 (de) 1995-06-08
HU9201805D0 (en) 1992-08-28
WO1991008219A1 (fr) 1991-06-13
NO301232B1 (no) 1997-09-29
AU6884191A (en) 1991-06-26
IL96501A0 (en) 1991-08-16
DK0430386T3 (da) 1995-09-04
CN1052677A (zh) 1991-07-03
JP2996723B2 (ja) 2000-01-11
HUT67420A (en) 1995-04-28
KR927003620A (ko) 1992-12-18
JPH05503080A (ja) 1993-05-27
IL96501A (en) 1997-07-13
FI102902B (fi) 1999-03-15
EP0430386A1 (fr) 1991-06-05
PT96035B (pt) 1998-01-30

Similar Documents

Publication Publication Date Title
ZA918570B (en) Azasteroid compounds for the treatment of prostatic hypertrophy,their preparation and use
IL123638A0 (en) Microemulsions for use as vehicles for administration of active compounds
DE60216630D1 (de) Verwendung von öestrogen in kombination mit progestogen für die hormonsubstitutions-therapie
EP0256668A3 (en) Method for treating male sexual dysfunction
AU562646B2 (en) 1-alkyl-androsta-1, 4-diene-3, 17-diones
AU649239B2 (en) 14-alpha,17-alpha-bridged 16-hydroxyestratrienes
MY100512A (en) New 6-or 7-methlenandrosta-1, 4-diene-3, 17-dione derivatives and process for their preparation.
IE42168L (en) 1-alpha-hydroxy and alkanoyloxy-steroids
IL110530A0 (en) 15, 15-Dialkyl-substituted derivatives of estradiol and pharmaceutical compositions thereof
ES8704897A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas
HUT43618A (en) Process for producing 1-methyl-15 alpha-alkyl-androsta-1,4-dien-3,17-dion derivatives and pharmaceutical compositions containing them
MX9804290A (es) Derivados de aminoalcohol, metodos para su produccion y medicamentos que los contienen.
GR3022869T3 (en) Process for producing 4-pregnene-3,20-dione and its derivatives
UA5533A1 (uk) Спосіб одержання ін'єкційної форми дисульфіраму
HU9902219D0 (en) Process for the treatment of retching and sexual dysfunction by use of benz [cd]indole-6-carboxamides
MX9407369A (es) Compuestos 14-aminoesteroides novedosos desoxi y oxigeno sustituidos que contienen azucar.
MX9701531A (es) Terapia de combinacion para tratar la osteoporosis-polifosfonatos o progestinas y agonistas de estrogenos.
UA6100A1 (uk) Спосіб моделювання цукрового діабету
HU203765B (en) Process for producing 17-alpha-hydroxy-pregna-4,9(11)-diene-3,20-dione derivatives